CJC-1295 DAC (5mg)

CJC-1295 DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed for elite physiological optimization. By incorporating the Drug Affinity Complex (DAC), this peptide offers a significantly extended half-life, providing a sustained stimulus for the endogenous secretion of Growth Hormone (GH) and Insulin-like Growth Factor 1 (IGF-1).

Primary Mechanisms of Action:

• Pulsatile GH Secretion: Mimics natural GHRH to stimulate the anterior pituitary, promoting consistent growth hormone release without disrupting natural biorhythms.

• Tissue Repair & Regeneration: Accelerated IGF-1 levels support the repair of connective tissues, muscle fibers, and integumentary (skin) health.

• Adipose Metabolism: Facilitates lipolysis, aiding the body in the mobilization and utilization of stored fats for energy.

• Deep Sleep Optimization: Enhanced GH levels are associated with improved slow-wave sleep cycles, critical for neurological and physical recuperation.

The NuroSynthiX Standard

Our CJC-1295 DAC is synthesized at 99%+ purity, ensuring maximum binding affinity and systemic stability. At NuroSynthiX, we prioritize molecular integrity to ensure that every 5mg vial delivers predictable, high-performance results.

FDA Compliance & Research Disclaimer

IMPORTANT: This product is intended for research and laboratory use only. It is not intended for human consumption or for the diagnosis, treatment, cure, or prevention of any disease.

The statements regarding CJC-1295 DAC have not been evaluated by the Food and Drug Administration (FDA). This product is not an FDA-approved medication. NuroSynthiX strictly prohibits the use of its products for any purpose other than professional research. Always ensure compliance with local and federal regulations regarding the handling of research peptides.